Human Gene TherapyVol. 19, No. 1 EditorialAdverse Events in Gene Transfer Trials and an Agenda for the New YearJames M. WilsonJames M. WilsonSearch for more papers by this authorPublished Online:29 Jan 2008https://doi.org/10.1089/hum.2008.0104AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Adverse Events in Gene Transfer Trials and an Agenda for the New Year." , 19(1), pp. 1–2FiguresReferencesRelatedDetailsCited ByDystrophin Gene Replacement and Gene Repair Therapy for Duchenne Muscular Dystrophy in 2016: An Interview Dongsheng Duan22 March 2016 | Human Gene Therapy Clinical Development, Vol. 27, No. 1Baculovirus as delivery system for gene transfer during hypothermic organ preservation28 May 2011 | Transplant International, Vol. 24, No. 8Historical Perspective18 July 2011Baculovirus as vectors for human cells and applications in organ transplantationJournal of Invertebrate Pathology, Vol. 107Current challenges of pharmacovigilance in bleeding disorders: converting the burden to benefit16 September 2009 | Haemophilia, Vol. 16, No. 2Accepting Risk in Clinical Research: Is the Gene Therapy Field Becoming Too Risk-averse?Molecular Therapy, Vol. 17, No. 11Succès de la thérapie génique d’un modèle murin de porphyrie érythropoïétique congénitale15 June 2008 | médecine/sciences, Vol. 24, No. 6-7More trouble ahead; is gene therapy coming of age?13 April 2008 | Expert Opinion on Biological Therapy, Vol. 8, No. 5 Volume 19Issue 1Jan 2008 InformationMary Ann Liebert, Inc.To cite this article:James M. Wilson.Adverse Events in Gene Transfer Trials and an Agenda for the New Year.Human Gene Therapy.Jan 2008.1-2.http://doi.org/10.1089/hum.2008.0104Published in Volume: 19 Issue 1: January 29, 2008Online Ahead of Print:January 22, 2008PDF download